We kickstarted Rebalance Cohort 05 in November 2022 with 13 diverse founders from Delhi NCR, Bangalore, Hyderabad, Goa, and Mumbai. We recently hosted our demo day over zoom where 7 companies showcased what they’re building across material sciences, deep tech/clean mobility, HR tech, consumer tech, alco-beverages, beauty tech, and media…

D-NOME is a synthetic biology company from India on a mission to democratize molecular diagnostics with the world’s first device-less PCR tech, enabling precision & personalized medicine at scale. Their technology meets the WHO ASSURED criteria (affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free, and deliverable to end-users) for medical…

1 in 5 children has a behavioral health issue, globally. The incidence rate of developmental differences, delays, and disabilities in children is growing at an alarming rate. Whether it is Dyslexia, ADHD, Autism, speech delays, or issues such as anxiety, one in five children needs help. India ranks #1 on…

Rebalance is India’s first set of initiatives on a mission to accelerate diversity in founders & venture capital. We run an early-stage accelerator and angel community that shapes and invests up to $150K in companies with at least one woman as a co-founder. Our goal is to arm and exponentially…

India’s fintech inclusion story is nothing short of a visible, multi-generational shift in consumer behavior. It’s hard to imagine a cashless shopping/purchase experience, today, even though UPI and digital payments are only a decade-old phenomenon. With 400M digital shoppers, brands and businesses can now reach the population that was previously…

Parenting is a joy that overwhelms most first-time parents. — There are as many theories as there are babies, and modern parents raising children in the digital age are bombarded with advice/choices. Vaishnavi and Viswanathan’s experience was no different when they became parents in 2015. Like every conscious parent who wants the best for their child, they wanted to make…

1 in 6 people worldwide suffer from neuro-psychiatric and neuro-oncological disorders. These disorders are the third-largest contributor to the global burden of disease and are projected to have an economic cost of $16.3Tn by 2030 — higher than chronic respiratory diseases, and diabetes. For patients, it’s a race against time…

Rebalance is India’s first set of initiatives on a mission to accelerate diversity in founders & venture capital. We run an early-stage accelerator that shapes and invests in companies with at least one woman as a co-founder. We invest through Rebalance Angel Community and co-invest alongside 90+ VC partners across…

When we launched Rebalance in 2019, we couldn’t have imagined a world-wide slowdown hitting us during Rebalance Accelerator Cohort 2 in early March 2020. …